Longevity Stocks

Petri dish

We are getting close to a new year, a time when any people establish a resolution to improve their health. Who doesn’t want to live longer and healthier? The wealthy are certainly on board. Paul Allen, co-founder of Microsoft (MSFT) created the Allen Institute for Cell Science to develop treatments for diseases related to aging. Peter Thiel, PayPal (PYPL) co-founder, has donated money to the SENS Research Foundation, a longevity organization. Adam Neumann, the CEO of WeWork, has invested in the anti-aging company Life Biosciences.

There are several companies working on helping you achieve a greater longevity, which are involved in targeting human aging and degenerative diseases. Here are several that are close to longevity pure plays.

Lineage Cell Therapeutics, Inc. (LCTX) develops and markets therapies for the treatment of Various degenerative diseases including age-related macular degeneration, acute spinal cord injuries, non-small cell lung cancer, and various other diseases and disorders. The stock has a market cap of $262 million and has been generating negative earnings. It has $30.7 million in total cash and $3.9 million in long term debt.

Unity Biotechnology, Inc. (UBX), is a biotechnology company involved in the research and development of therapeutics to extend human life and health. The company’s lead drug candidates include treatments for musculoskeletal/ osteoarthritis disease, moderate-to-severe osteoarthritis of the knee, diabetic macular edema, and ophthalmologic diseases. The stock has a market cap of $327 million and has been generating negative earnings. It has $1277 million in total cash and $13 million in long term deferred liabilities.

Cohbar (CWBR) is a clinical stage biotechnology company which concentrates  on the research and development of mitochondria based therapeutics, an emerging class of drugs for the treatment of chronic and age-related diseases. CohBars therapeutics offer the potential to treat a broad range of diseases, including nonalcoholic steatohepatitis, obesity, fibrotic diseases, cancer, acute respiratory distress syndrome, type 2 diabetes, and cardiovascular and neurodegenerative diseases. The company is even in a pre-clinical program for COVID-19 associated ARDS. This  Menlo Park, California based company was founded in 2007. The stock has a market cap of $74 million and has been generating negative earnings. It has $12 million in total cash and long term debt of $3 million.

1 2
View single page >> |

Disclosure: Author didn’t own any of the above at the time the article was written.

Disclaimer: This article is designed to provide information. It is provided with the ...

more
How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.